EUVIMEDEUVIMED entdecken
Crossref

Targeted mRNA Delivery Using Bispecific Antibody-Lipid Nanoparticle Complexes

James Collin Hickey, Tracoyia Roach, Britteny Cassaidy, Rudolf Hergesheimer, Noah Franklin, Jeffrey Morin, Sarah Wagman, Justin Cohen, David Morrissey, Javier Chaparro-Riggers, Patrick Lim Soo iD

Molecular Pharmaceutics · 03.08.2026 · 23 (8) · 4190-4202

DOI: 10.1021/acs.molpharmaceut.6c00239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 20.07.2026. Verfasst von James Collin Hickey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Discovery, BioMedicine Design, Pfizer Inc., Cambridge, Massachusetts02139, United States. Hauptthemen laut MEDLINE: Nanoparticles, Antibodies, Bispecific, Lipids, RNA, Messenger. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) are highly modular drug nanocarriers that have significantly progressed in the development and application of novel RNA therapeutics. While instrumental in current vaccine and hepatic gene therapy applications, extrahepatic LNP delivery remains a challenging hurdle, severely limiting clinical applications for individualized therapies that require cellular- and tissue-specific enrichment. Novel platform development remains needed to generate targeted LNPs capable of modeling targeted uptake in vitro prior to in vivo applications. Herein, we developed and utilized an antibody-based targeting bispecific-LNP (TbsAb-LNP) platform simultaneously binding LNP polyethylene glycol motifs and desired cell surface markers. By colocalizing TbsAb-LNP complexes with desired cell surface markers, we enable mRNA-LNP accumulation in the desired cell types. We additionally assessed the endosomal efficiency kinetics of TbsAb-LNP complexes generated at various bispecific loading ratios in a Galectin-9 in vitro expression model. Leveraging this facile and modular platform that eliminates the need for complex chemical conjugation approaches, we successfully achieved targeted LNP delivery to xhuCD3-expressing lymphoblasts and xmTfR1-expressing cell lines in vitro as well as xmTfR1-expressing cells in vivo. Enrichment of TbsAb-LNPs to splenic cells demonstrates the potential utility of this platform for clinical vaccine and T-cell delivery applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesAntibodies, BispecificLipidsRNA, MessengerHumansAnimalsMicePolyethylene GlycolsDrug Delivery SystemsLiposomes

Stichwörter der Autor:innen

RNA therapeuticsendosomal escapelipid nanoparticlesnanoparticlestargeted LNPs

Substanzen

Antibodies, BispecificLipidsRNA, MessengerLipid NanoparticlesPolyethylene GlycolsLiposomes

Autor:innen und Institutionen

  • Molecular Discovery, BioMedicine Design, Pfizer Inc., Cambridge, Massachusetts02139, United States.
  • Inflammation and Immunology Research Unit, Pfizer Inc., Cambridge, Massachusetts02139, United States.
  • Discovery Biology and Pharmacology, Pfizer Inc., Groton, Connecticut06340, United States.
  • Cancer Immunology Discovery Unit, BioMedicine Design, Pfizer Inc., La Jolla, California92121, United States.
  • Drug Safety Research and Development, Pfizer Inc, Cambridge, Massachusetts02139, United States.
  • Gene Editing, BioMedicine Design, Pfizer Inc., Cambridge, Massachusetts02139, United States.

ORCID-Profile: Patrick Lim Soo

Zitieren

APA

Hickey, J. C., Roach, T., Cassaidy, B., Hergesheimer, R., Franklin, N., Morin, J., Wagman, S., Cohen, J., Morrissey, D., Chaparro-Riggers, J., & Lim Soo, P. (2026). Targeted mRNA Delivery Using Bispecific Antibody-Lipid Nanoparticle Complexes. Molecular Pharmaceutics, 23(8), 4190-4202. https://doi.org/10.1021/acs.molpharmaceut.6c00239

Vancouver

Hickey JC, Roach T, Cassaidy B, Hergesheimer R, Franklin N, Morin J, et al. Targeted mRNA Delivery Using Bispecific Antibody-Lipid Nanoparticle Complexes. Molecular Pharmaceutics. 2026;23(8):4190-4202. doi:10.1021/acs.molpharmaceut.6c00239

BibTeX
@article{Hickey2026,
  author = {Hickey, James Collin and Roach, Tracoyia and Cassaidy, Britteny and Hergesheimer, Rudolf and Franklin, Noah and Morin, Jeffrey and Wagman, Sarah and Cohen, Justin and Morrissey, David and Chaparro-Riggers, Javier and Lim Soo, Patrick},
  title = {Targeted mRNA Delivery Using Bispecific Antibody-Lipid Nanoparticle Complexes},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {8},
  pages = {4190--4202},
  doi = {10.1021/acs.molpharmaceut.6c00239}
}
Kostenlos starten →